Skip to main content

Table 2 Comparison of Normouricemic and Hyperuricemic Groups

From: Prevalence of asymptomatic hyperuricemia and its association with prediabetes, dyslipidemia and subclinical inflammation markers among young healthy adults in Qatar

Parameter

Normouricemic (N=678) Mean (SD)

Hyperuricemic (N=184) Mean (SD)

p-value

Hemoglobin (g/dL)

13.17 (1.88)

14.60 (1.56)

<0.001

Folate (nmol/L)

20.83 (7.07)

19.05 (6.66)

0.002

RBC (106/µL)

4.87 (0.57)

5.29 (0.51)

<0.001

TIBC (µmol/L)

62.44 (10.08)

58.03 (7.89)

<0.001

WBC (103/µL)

6.76 (2.00)

6.91 (1.72)

0.348

Monocyte (%)

7.27 (1.84)

7.74 (1.97)

0.002

Platelet (103/µL)

255.5 (65.82)

239.7 (60.11)

0.004

HDL (mmol/L)

1.47 (0.37)

1.19 (0.29)

<0.001

LDL (mmol/L)

2.75 (0.73)

3.07 (0.79)

<0.001

*Triglycerides (mmol/L)

0.90 (0.63, 1.30)

1.2 (0.81, 1.60)

<0.001

*C-peptide (ng/mL)

1.77 (1.31, 2.55)

2.38 (1.72, 3.49)

<0.001

Glucose (mmol/L)

4.94 (0.74)

5.21 (0.63)

<0.001

HbA1c (%)

5.21 (0.39)

5.32 (0.50)

0.002

*Ferritin (µg/L)

25 (9, 67)

94 (53, 146.5)

<0.001

*MHR

4.94 (3.82, 6.46)

6.60 (5.18, 8.08)

<0.001

  1. *Variables are not normally distributed, and accordingly their medians are presented instead of their means, and their interquartile ranges are presented instead of their standard deviations, and Mann-Whitney U tests were used to produce their p-values instead of t-tests.
Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us